HiberGene Diagnostics (Dublin) has announced the appointment of Tony Hill as CEO. Hill joins HiberGene from Innogenetics, an international diagnostics company, where he was global sales director. Prior to this, he was vice president at OraSure Technologies, notes a press release issued by the company.
HiberGene has developed a molecular diagnostic test for meningococcus and plans to develop a test for pneumococcal meningitis. Using a novel rapid amplification platform, the company has produced a rapid and sensitive diagnostic test that can be used in almost any clinical or laboratory setting. The company is currently fundraising to progress the tests for meningitis through to commercialization and to fund further ongoing research and development on a complementary range of human infectious diseases.
HiberGene is based at NovaUCD, the Centre for New Ventures and Entrepreneurs at University College Dublin, Ireland.